{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:23:11Z","timestamp":1772767391116,"version":"3.50.1"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research, Govt. of India","doi-asserted-by":"publisher","award":["45\/15\/2011\/IMM-BMS"],"award-info":[{"award-number":["45\/15\/2011\/IMM-BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["tuberculosisjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.tube.2016.03.006","type":"journal-article","created":{"date-parts":[[2016,3,27]],"date-time":"2016-03-27T09:10:46Z","timestamp":1459069846000},"page":"149-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Current perspective in tuberculosis vaccine development for high TB endemic regions"],"prefix":"10.1016","volume":"98","author":[{"given":"Aliabbas A.","family":"Husain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatim F.","family":"Daginawala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lokendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajpal S.","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2016.03.006_bib1","series-title":"Global tuberculosis report","year":"2014"},{"issue":"9","key":"10.1016\/j.tube.2016.03.006_bib2","doi-asserted-by":"crossref","first-page":"e74652","DOI":"10.1371\/journal.pone.0074652","article-title":"Laboratory investigations on the diagnosis of tuberculosis in the malnourished tribal population of Melghat, India","volume":"8","author":"Kashyap","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2016.03.006_bib3","first-page":"597","article-title":"Tuberculosis in India: the continuing challenge","volume":"105","author":"Kashyap","year":"2013","journal-title":"Curr Sci"},{"key":"10.1016\/j.tube.2016.03.006_bib4","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-3156.2011.02777.x","article-title":"Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosis","volume":"16","author":"Mwaba","year":"2011","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.tube.2016.03.006_bib5","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1128\/IAI.71.11.6411-6419.2003","article-title":"Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination","volume":"71","author":"Buddle","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2016.03.006_bib6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1586\/erv.11.28","article-title":"Tuberculosis vaccines in clinical trials","volume":"10","author":"Rowland","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.tube.2016.03.006_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2223\/JPED.1499","article-title":"Vacina BCG: efficacy and indications for vaccination and revaccination","volume":"82","author":"Barreto","year":"2006","journal-title":"J\u00a0Pediatr (Rio J)"},{"key":"10.1016\/j.tube.2016.03.006_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1590\/S0034-89102007000800009","article-title":"BCG vaccine against tuberculosis: its protective effect and vaccination policies","volume":"1","author":"Pereira","year":"2007","journal-title":"Rev Sa\u00fade P\u00fablica"},{"key":"10.1016\/j.tube.2016.03.006_bib9","doi-asserted-by":"crossref","first-page":"e1001012","DOI":"10.1371\/journal.pmed.1001012","article-title":"The BCG World Atlas: a database of global BCG vaccination policies and practices","volume":"8","author":"Zwerling","year":"2011","journal-title":"PLoS Med"},{"issue":"14","key":"10.1016\/j.tube.2016.03.006_bib10","first-page":"571","article-title":"Fifteen year follow up of trial of BCG vaccines in south India for tuberculosis prevention. 1999","volume":"137","author":"Tuberculosis Research Centre (ICMR)","year":"2013","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.tube.2016.03.006_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1086\/653533","article-title":"Decrease in the effectiveness of Bacille Calmette-Gu\u00e9rin vaccine against pulmonary tuberculosis: a consequence of increased immune suppression by microbial antioxidants, not overattenuation","volume":"51","author":"Kernodle","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tube.2016.03.006_bib12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/1040841X.2013.859125","article-title":"Challenges and solutions for a rational vaccine design for TB-endemic regions","volume":"41","author":"Gowthaman","year":"2015","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.tube.2016.03.006_bib13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/IAI.70.2.672-678.2002","article-title":"Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis","volume":"70","author":"Brandt","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2016.03.006_bib14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tube.2016.03.006_bib15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1183\/09031936.05.00109904","article-title":"The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?","volume":"26","author":"Mart\u00edn","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2016.03.006_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1473-3099(02)00182-2","article-title":"BCG \u2013 different strains, different vaccines?","volume":"2","author":"Behr","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tube.2016.03.006_bib17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.tube.2011.01.003","article-title":"Development of vaccines against tuberculosis","volume":"91","author":"Tyagi","year":"2011","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.tube.2016.03.006_bib18","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.4049\/jimmunol.162.11.6843","article-title":"Helminth- and Bacillus Calmette-Gu\u00e9rin-induced immunity in children sensitized in utero to filariasis and schistosomiasis","volume":"162","author":"Malhotra","year":"1999","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.tube.2016.03.006_bib19","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1016\/j.vaccine.2008.04.083","article-title":"Poor immunogenicity of BCG in helminth infected population is associated with increased in\u00a0vitro TGF-b production","volume":"26","author":"Elias","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2016.03.006_bib20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.tube.2009.09.004","article-title":"Ultraviolet radiation reduces resistance to Mycobacterium tuberculosis infection in BCG-vaccinated guinea pigs","volume":"89","author":"Jeevan","year":"2009","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.tube.2016.03.006_bib21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrmicro1419","article-title":"Advances in tuberculosis vaccine strategies","volume":"4","author":"Skeiky","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.tube.2016.03.006_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0264-410X(02)00447-4","article-title":"Novel TB vaccine; towards a strategy based on our understanding of BCG failure","volume":"21","author":"Agger","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2016.03.006_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tube.2003.08.010","article-title":"Immunology of tuberculosis and implications in vaccine development","volume":"84","author":"Flynn","year":"2004","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.tube.2016.03.006_bib24","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1128\/CMR.18.4.687-702.2005","article-title":"Vaccines for tuberculosis: novel concepts and recent progress","volume":"18","author":"Doherty","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.tube.2016.03.006_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1465-9921-11-169","article-title":"New approaches in the diagnosis and treatment of latent tuberculosis infection","volume":"11","author":"Ahmad","year":"2010","journal-title":"Respir Res"},{"key":"10.1016\/j.tube.2016.03.006_bib26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-2600(14)70033-5","article-title":"Progress in tuberculosis vaccine development and host-directed therapies-a state of the art review","volume":"2","author":"Kaufmann","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.tube.2016.03.006_bib27","first-page":"326","article-title":"Development of vaccines to control the worldwide tuberculosis pandemic","volume":"111","author":"Hoft","year":"2014","journal-title":"Mo Med"},{"key":"10.1016\/j.tube.2016.03.006_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijmm.2007.07.004","article-title":"Rational design of vaccines against tuberculosis directed by basic immunology","volume":"298","author":"Reece","year":"2008","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.tube.2016.03.006_bib29","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis","volume":"22","author":"Rodrigues","year":"1993","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.tube.2016.03.006_bib30","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2016.03.006_bib31","first-page":"119","article-title":"Influence of sex, age & nontuberculous infection at intake on the efficacy of BCG: re-analysis of 15-year data from a double-blind randomized control trial in South India","volume":"123","author":"Narayanan","year":"2006","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.tube.2016.03.006_bib32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF02097162","article-title":"The impact of the BCG vaccination program in Hungary on the tuberculosis problem in children","volume":"151","author":"Vad\u00e1sz","year":"1974","journal-title":"Pneumonologie"},{"key":"10.1016\/j.tube.2016.03.006_bib33","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC clusterrandomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2016.03.006_bib34","doi-asserted-by":"crossref","first-page":"e5934","DOI":"10.1371\/journal.pone.0005934","article-title":"Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A","volume":"4","author":"Whelan","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2016.03.006_bib35","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/0140-6736(92)90794-4","article-title":"Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi","volume":"339","author":"Ponnighaus","year":"1992","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.tube.2016.03.006_bib36","article-title":"Assessment of immune response to repeat stimulation with BCG vaccine using in\u00a0vitro PBMC model","volume":"8","author":"Kashyap","year":"2010","journal-title":"J\u00a0Immune Based Ther Vaccines"},{"key":"10.1016\/j.tube.2016.03.006_bib37","first-page":"7","article-title":"Effect of repeat dose of BCG vaccination on humoral response in mice model","volume":"49","author":"Husain","year":"2011","journal-title":"Indian J Exp Biol"},{"key":"10.1016\/j.tube.2016.03.006_bib38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.7774\/cevr.2016.5.1.31","article-title":"Assessment of immunological markers and booster effects of Ag85B peptides, Ag85B, and BCG in blood of BCG vaccinated children: a preliminary report","volume":"5","author":"Husain","year":"2016","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.tube.2016.03.006_bib39","unstructured":"Tuberculosis vaccine pipeline report. http:\/\/www.pipelinereport.org\/2014\/tb-vaccine. [accessed 04.03.14]."},{"key":"10.1016\/j.tube.2016.03.006_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1472-9792(12)70007-0","article-title":"Ten challenges for TB biomarkers","volume":"92","author":"Ottenhoff","year":"2012","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2016.03.006_bib41","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette\u2013Gu\u00e9rin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.tube.2016.03.006_bib42","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.vaccine.2006.03.017","article-title":"The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs","volume":"24","author":"Martin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2016.03.006_bib43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijid.2014.11.026","article-title":"Tuberculosis vaccines\u2013state of the art, and novel approaches to vaccine development","volume":"32","author":"Da Costa","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.tube.2016.03.006_bib44","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.coi.2009.05.016","article-title":"Heterologous prime-boost vaccination","volume":"21","author":"Lu","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.tube.2016.03.006_bib45","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(08)61036-3","article-title":"Tuberculosis vaccine development: goals, immunological design, and evaluation","volume":"372","author":"Hoft","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2016.03.006_bib46","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/infdis\/jit267","article-title":"Heterologous prime\/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus","volume":"208","author":"Fournillier","year":"2013","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.tube.2016.03.006_bib47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/2051013615593891","article-title":"Recent advances in the development of vaccines for tuberculosis","volume":"3","author":"Ahsan","year":"2015","journal-title":"Ther Adv Vaccines"},{"key":"10.1016\/j.tube.2016.03.006_bib48","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1128\/IAI.69.4.2714-2717.2001","article-title":"Boosting vaccine for tuberculosis","volume":"69","author":"Brooks","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2016.03.006_bib49","doi-asserted-by":"crossref","first-page":"e18773","DOI":"10.1371\/journal.pone.0018773","article-title":"Latency antigen \u03b1-crystallin based vaccination imparts a robust protection against TB by modulating the dynamics of pulmonary cytokines","volume":"6","author":"Dey","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2016.03.006_bib50","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.coi.2009.05.017","article-title":"Tuberculosis vaccine research: the impact of immunology","volume":"21","author":"Barker","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.tube.2016.03.006_bib51","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1080\/21645515.2015.1042193","article-title":"Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine","volume":"11","author":"Zhang","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.tube.2016.03.006_bib52","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/vaccines2030515","article-title":"Peptide vaccine: progress and challenges","volume":"2","author":"Li","year":"2014","journal-title":"Vaccines"},{"key":"10.1016\/j.tube.2016.03.006_bib53","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1586\/14760584.7.5.635","article-title":"Tuberculosis: vaccines in the pipeline","volume":"7","author":"Ly","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.tube.2016.03.006_bib54","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.molmed.2012.07.008","article-title":"Lipidated promiscuous peptides vaccine for tuberculosis-endemic regions","volume":"18","author":"Gowthaman","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.tube.2016.03.006_bib55","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nrd2224","article-title":"More than one reason to rethink the use of peptides in vaccine design","volume":"6","author":"Purcell","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.tube.2016.03.006_bib56","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.immuni.2010.09.017","article-title":"Reverse vaccinology: developing vaccines in the era of genomics","volume":"33","author":"Sette","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.tube.2016.03.006_bib57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2172-13-13","article-title":"Potential T cell epitopes of Mycobacterium tuberculosis that can instigate molecular mimicry against host: implications in autoimmune pathogenesis","volume":"13","author":"Chodisetti","year":"2012","journal-title":"BMC Immunol"},{"key":"10.1016\/j.tube.2016.03.006_bib58","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/1521-4141(200006)30:6<1724::AID-IMMU1724>3.0.CO;2-A","article-title":"Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen","volume":"30","author":"Olsen","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tube.2016.03.006_bib59","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1128\/IAI.69.6.4164-4167.2001","article-title":"gp96-Peptide vaccination of mice against intracellular bacteria","volume":"69","author":"Zugel","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2016.03.006_bib60","first-page":"94","article-title":"Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A","volume":"87","author":"Sugawaraa","year":"2006","journal-title":"J\u00a0Tube"},{"key":"10.1016\/j.tube.2016.03.006_bib61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7774\/cevr.2015.4.1.83","article-title":"Comparative evaluation of booster efficacies of BCG, Ag85B, and Ag85B peptides based vaccines to boost BCG induced immunity in BALB\/c mice: a pilot study","volume":"4","author":"Husain","year":"2015","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.tube.2016.03.006_bib62","article-title":"Heterologous prime boost regimes with N-terminal peptides of Ag85B induces better protection than Ag85B and BCG in murine model of tuberculosis","author":"Husain","year":"2015","journal-title":"Int J Pept Res Ther"},{"issue":"4","key":"10.1016\/j.tube.2016.03.006_bib63","first-page":"5","article-title":"The importance of animal models in tuberculosis vaccine development","volume":"18","author":"Acosta","year":"2011","journal-title":"Malays J Med Sci"},{"issue":"6","key":"10.1016\/j.tube.2016.03.006_bib64","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2217\/17460913.2.6.667","article-title":"Use of animal models in the development of human vaccines","volume":"2","author":"Gerdts","year":"2007","journal-title":"Future Microbiol"},{"key":"10.1016\/j.tube.2016.03.006_bib65","first-page":"575","article-title":"Three Rs achievements in vaccinology","author":"Hendriksen","year":"2008","journal-title":"AATEX"},{"issue":"5\u20136","key":"10.1016\/j.tube.2016.03.006_bib66","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tube.2005.08.008","article-title":"Animal models of tuberculosis","volume":"85","author":"Gupta","year":"2005","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.tube.2016.03.006_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2016.01.049","article-title":"A\u00a0novel liposome adjuvant DPC mediates Mycobacterium tuberculosis subunit vaccine well to induce cell-mediated immunity and high protective efficacy in mice","author":"Liu","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2016.03.006_bib68","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.meegid.2016.01.027","article-title":"Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine","volume":"39","author":"Mosavat","year":"2016","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.tube.2016.03.006_bib69","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tube.2015.10.010","article-title":"MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice","volume":"96","author":"Aguilo","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.tube.2016.03.006_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micpath.2016.01.006","article-title":"Recombinant BCG prime and PPE protein boost provides potent protection against acute Mycobacterium tuberculosis infection in mice","volume":"93","author":"Yang","year":"2016","journal-title":"Microb Pathog"},{"key":"10.1016\/j.tube.2016.03.006_bib71","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.vaccine.2011.12.059","article-title":"Epitope based recombinant BCG vaccine elicits specific Th1 polarized immune responses in BALB\/c mice","volume":"30","author":"Christy","year":"2012","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.tube.2016.03.006_bib72","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.123.3.445","article-title":"Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues","volume":"123","author":"McCune","year":"1966","journal-title":"J\u00a0Exp Med"},{"issue":"2","key":"10.1016\/j.tube.2016.03.006_bib73","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tube.2013.11.003","article-title":"A\u00a0review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data","volume":"94","author":"McShane","year":"2014","journal-title":"Tuberculosis (Edinb)"},{"issue":"6","key":"10.1016\/j.tube.2016.03.006_bib74","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.vaccine.2015.12.059","article-title":"Lipoprotein LpqS deficient M. tuberculosis mutant is attenuated for virulence in\u00a0vivo and shows protective efficacy better than BCG in guinea pigs","volume":"34","author":"Sakthi","year":"2016","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.tube.2016.03.006_bib75","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.vaccine.2015.03.083","article-title":"Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system","volume":"33","author":"Bottai","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.tube.2016.03.006_bib76","doi-asserted-by":"crossref","first-page":"e66310","DOI":"10.1371\/journal.pone.0066310","article-title":"Vaccination with recombinant Mycobacterium tuberculosis PknD attenuates bacterial dissemination to the brain in guinea pigs","volume":"8","author":"Skerry","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2016.03.006_bib77","series-title":"Non-human primates and medical research","first-page":"39","article-title":"Tuberculosis and bacterial infection","author":"Good","year":"1973"},{"key":"10.1016\/j.tube.2016.03.006_bib78","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1128\/IAI.71.10.5831-5844.2003","article-title":"Experimental Mycobacterium tuberculosis infection of cynomolous macaques close by resembles the various manifestations of human M.\u00a0tuberculosis infection","volume":"71","author":"Capuano","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2016.03.006_bib79","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1016\/j.vaccine.2004.11.051","article-title":"Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6","volume":"23","author":"Langermans","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2016.03.006_bib80","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/j.vaccine.2005.01.057","article-title":"Novel recombinant BCG and DNA vaccination against tuberculosis in a cynomolgous monkey model","volume":"23","author":"Kita","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2016.03.006_bib81","doi-asserted-by":"crossref","first-page":"8533","DOI":"10.1038\/ncomms9533","article-title":"Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosis","volume":"6","author":"Kaushal","year":"2015","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.tube.2016.03.006_bib82","doi-asserted-by":"crossref","first-page":"e0135009","DOI":"10.1371\/journal.pone.0135009","article-title":"AdHu5Ag85A respiratory mucosal boost immunization enhances protection against pulmonary tuberculosis in BCG-primed non-human primates","volume":"10","author":"Jeyanathan","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.tube.2016.03.006_bib83","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/CVI.00289-15","article-title":"Evaluation of the immunogenicity of Mycobacterium bovis BCG delivered by aerosol to the lungs of macaques","volume":"22","author":"White","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.tube.2016.03.006_bib84","unstructured":"Tuberculosis India-2014. www.downtoearth.org.in\/blog\/tuberculosis-india2014-46252. [accessed 10.02.16]."},{"issue":"11 Suppl.\u00a03","key":"10.1016\/j.tube.2016.03.006_bib85","first-page":"S289","article-title":"Review of the Indian market of anti-tuberculosis drugs: focus on the utilisation of rifampicin-based products","volume":"3","author":"Catalani","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2016.03.006_bib86","unstructured":"2015 report on tuberculosis research funding trends, 2005\u20132014: a decade of data. http:\/\/www.treatmentactiongroup.org\/tbrd2015. [accessed 10.02.16]."},{"key":"10.1016\/j.tube.2016.03.006_bib87","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.clim.2007.07.007","article-title":"Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice","volume":"125","author":"Kalra","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.tube.2016.03.006_bib88","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/infdis\/jir548","article-title":"Promiscuous peptide of 16 kDa antigen linked to Pam2Cys protects against Mycobacterium tuberculosis by evoking enduring memory T-cell response","volume":"204","author":"Gowthaman","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.tube.2016.03.006_bib89","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/j.micinf.2006.04.025","article-title":"A\u00a0multivalent combination of experimental antituberculosis DNA vaccines based on Ag85B and regions of difference antigens","volume":"8","author":"Grover","year":"2006","journal-title":"Microbes Infect"},{"key":"10.1016\/j.tube.2016.03.006_bib90","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1016\/j.vaccine.2005.03.056","article-title":"Elicitation of ef\ufb01cient, protective immune responses by using DNA vaccines against tuberculosis","volume":"23","author":"Khera","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2016.03.006_bib91","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-3083.2005.01569.x","article-title":"Increased expression of Mycobacterium tuberculosis 19 kDa lipoprotein obliterates the protective efficacy of BCG by polarizing host immune responses to the Th2 subtype","volume":"61","author":"Rao","year":"2005","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.tube.2016.03.006_bib92","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-3083.2003.01321.x","article-title":"Modulation of host immune responses by overexpression of immunodominant antigens of Mycobacterium tuberculosis in Bacille Calmette e Guerin","volume":"58","author":"Rao","year":"2003","journal-title":"Scand J Immunol"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979215302754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979215302754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T10:55:23Z","timestamp":1692269723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979215302754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":92,"alternative-id":["S1472979215302754"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2016.03.006","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current perspective in tuberculosis vaccine development for high TB endemic regions","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2016.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}